Edition:
United States

Kyowa Hakko Kirin Co Ltd (4151.T)

4151.T on Tokyo Stock Exchange

2,010JPY
12:59am EDT
Change (% chg)

¥-16 (-0.79%)
Prev Close
¥2,026
Open
¥2,021
Day's High
¥2,034
Day's Low
¥2,009
Volume
591,600
Avg. Vol
1,233,162
52-wk High
¥2,087
52-wk Low
¥1,412

Select another date:

Tue, Apr 18 2017

BRIEF-Ultragenyx, Kyowa Hakko Kirin, Kyowa Kirin announce positive 24-week data from adult phase 3 study of burosumab

* Ultragenyx, Kyowa Hakko Kirin and Kyowa Kirin International announce positive 24-week data from adult phase 3 study of Burosumab (KRN23) in X-linked hypophosphatemia

BRIEF-Kyowa Hakko Kirin Co Ltd's phase 3 study of mogamulizumab a met its primary endpoint

* Kyowa Hakko Kirin Co Ltd -announced global phase 3 study of mogamulizumab in patients with cutaneous t-cell lymphoma met its primary endpoint

BRIEF-Kyowa Hakko Kirin sets up KYOWA KIRIN FRONTIER Co., Ltd.

Feb 1 Kyowa Hakko Kirin Co Ltd : * Says it set up KYOWA KIRIN FRONTIER Co., Ltd. * Says the capital is 100 million yen Source text in Japanese:https://goo.gl/pbfRNt Further company coverage: (Beijing Headline News)

Select another date:

More From Around the Web